Institutional investors purchased a net $286.0 thousand shares of NBY during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 4.61% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACOB ASSET MANAGEMENT OF NEW YO... Bought 166.1 Thousand shares of NovaBay Pharmaceuticals I...
DEUTSCHE BANK SECURITIES, INC. Bought 101.8 Thousand shares of NovaBay Pharmaceuticals I...